Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68


Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.

Kim YA, Estevez J, Le A, Israelski D, Baatarkhuu O, Sarantuya T, Narantsetseg S, Nymadawa P, H Le R, Yuen MF, Dusheiko G, Rizzetto M, Nguyen MH.

BMJ Open Gastroenterol. 2016 Nov 10;3(1):e000119. eCollection 2016.


Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults? Study protocol for a randomized controlled trial.

Green EP, Catalani C, Diero L, Carter EJ, Gardner A, Ndwiga C, Keny A, Owiti P, Israelski D, Biondich P.

Trials. 2015 Apr 9;16:141. doi: 10.1186/s13063-015-0558-8.


HIV drug resistance mutations in proviral DNA from a community treatment program.

Derache A, Shin HS, Balamane M, White E, Israelski D, Klausner JD, Freeman AH, Katzenstein D.

PLoS One. 2015 Jan 30;10(1):e0117430. doi: 10.1371/journal.pone.0117430. eCollection 2015.


A clinical decision support system for integrating tuberculosis and HIV care in Kenya: a human-centered design approach.

Catalani C, Green E, Owiti P, Keny A, Diero L, Yeung A, Israelski D, Biondich P.

PLoS One. 2014 Aug 29;9(8):e103205. doi: 10.1371/journal.pone.0103205. eCollection 2014.


mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature.

Catalani C, Philbrick W, Fraser H, Mechael P, Israelski DM.

Open AIDS J. 2013 Aug 13;7:17-41. doi: 10.2174/1874613620130812003. eCollection 2013.


Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.

Melikian GL, Rhee SY, Varghese V, Porter D, White K, Taylor J, Towner W, Troia P, Burack J, Dejesus E, Robbins GK, Razzeca K, Kagan R, Liu TF, Fessel WJ, Israelski D, Shafer RW.

J Antimicrob Chemother. 2014 Jan;69(1):12-20. doi: 10.1093/jac/dkt316. Epub 2013 Aug 9.


Community health workers and mobile technology: a systematic review of the literature.

Braun R, Catalani C, Wimbush J, Israelski D.

PLoS One. 2013 Jun 12;8(6):e65772. doi: 10.1371/journal.pone.0065772. Print 2013. Review.


Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.

Melikian GL, Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W, Troia-Cancio PV, Zolopa A, Robbins GK, Kagan R, Israelski D, Shafer RW.

Antimicrob Agents Chemother. 2012 May;56(5):2305-13. doi: 10.1128/AAC.05487-11. Epub 2012 Feb 13.


Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics.

Trafton JA, Sorrell JT, Holodniy M, Pierson H, Link P, Combs A, Israelski D.

J Behav Health Serv Res. 2012 Apr;39(2):158-73. doi: 10.1007/s11414-011-9254-y.


Utilization of psychiatric services among low-income HIV-infected patients with psychiatric comorbidity.

Soller M, Kharrazi N, Prentiss D, Cummings S, Balmas G, Koopman C, Israelski D.

AIDS Care. 2011 Nov;23(11):1351-9. doi: 10.1080/09540121.2011.565024. Epub 2011 Jul 18.


Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa.

Thairu L, Katzenstein D, Israelski D.

AIDS Care. 2011 Jul;23(7):814-21. doi: 10.1080/09540121.2010.541416. Epub 2011 Jun 24.


Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.

Renault CA, Israelski DM, Levy V, Fujikawa BK, Kellogg TA, Klausner JD.

Sex Health. 2011 Mar;8(1):69-73. doi: 10.1071/SH10030.


Validation of Microcapillary Flow Cytometry for Community-Based CD4+ T Lymphocyte Enumeration in Remote Burkina Faso.

Renault CA, Traore A, Machekano RN, Israelski DM.

Open AIDS J. 2010 Dec 30;4:171-5. doi: 10.2174/1874613601004010171.


Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.

Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D.

J Womens Health (Larchmt). 2010 Apr;19(4):709-12. doi: 10.1089/jwh.2009.1412.


Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.

Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD.

Open Virol J. 2010;4:88-93. doi: 10.2174/1874357901004010088. Epub 2010 May 28.


Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.

Bhattacharya D, Katzenstein D, Wong A, Israelski D, Imperial JC, Keeffe EB, Donovan RM.

Int J STD AIDS. 2008 Nov;19(11):780-1. doi: 10.1258/ijsa.2008.008020.


Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.

Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, Nolan GP, Nixon DF.

J Virol. 2008 Apr;82(7):3702-12. doi: 10.1128/JVI.01582-07. Epub 2008 Jan 23.


Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS.

Israelski DM, Prentiss DE, Lubega S, Balmas G, Garcia P, Muhammad M, Cummings S, Koopman C.

AIDS Care. 2007 Feb;19(2):220-5.


Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs.

Levy V, Prentiss D, Balmas G, Chen S, Israelski D, Katzenstein D, Page-Shafer K.

J Immigr Minor Health. 2007 Jan;9(1):49-54.


Association-driven care and treatment: a model for community-based delivery of HIV/AIDS healthcare in resource-limited settings.

Kassaye SG, Ndayishimiye F, Binswanger H, Sall AY, Machekano R, Israelski DM.

AIDS. 2006 Jul 13;20(11):1561-2. No abstract available.


Supplemental Content

Loading ...
Support Center